Gefitinib

Category: Cancer



Gefitinib Overview

Gefitinib (ZD1839) (INN, /ftnb/, trade name Iressa)[1] is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR. It is marketed by AstraZeneca and Teva. Contents 1 Mechanism of action 2 Clinical uses 3 Experimental uses 4 Studies 4.1 EGFR diagnostic tes...

Read more Gefitinib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Gefitinib

Recent Gefitinib Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Gefitinib
  • Tablet: 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Gefitinib or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 September 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA